Prosecution Insights
Prosecution Insights
7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (86%) |
| Double-patenting + other | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALLEN, MICHAEL D | 1 | 32.6% | +48.7% |
| ALDARONDO, DASIA ALI | 1 | 0.0% | +0.0% |
| ZHU, JIANJIAN | 1 | 59.7% | +82.5% |
| SPENCE, JENNIFER SUZANNE | 1 | 65.8% | +47.7% |
| WENG, KAI H | 1 | 70.9% | +17.1% |
| DHAR, MATASHA | 1 | 44.7% | +50.1% |
| HALVORSON, MARK | 1 | 48.0% | +21.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18361056 | ENGINEERED CELLS WITH REDUCED GENE EXPRESSION TO MITIGATE IMMUNE CELL RECOGNITION | ALDARONDO, DASIA ALI | 53d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16826102 | METHODS FOR ENHANCING TCRab+ CELL DEPLETION EFFICIENCY | DHAR, MATASHA | 141d overdue |
| 17550311 | METHODS AND REAGENTS FOR CHARACTERIZING CAR T CELLS FOR THERAPIES | SPENCE, JENNIFER SUZANNE | 114d overdue |
| 16695894 | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE THEREOF | HALVORSON, MARK | 71d overdue |
| 17064241 | Plastic Jacket for Vial Labeling Systems | WENG, KAI H | 15d |
| 18450554 | METHOD FOR INHIBITING ADVENTITIOUS VIRAL INFECTION | ALLEN, MICHAEL D | 27d |
| 17841041 | SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE | ZHU, JIANJIAN | 76d |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| 1647 | 1 |
| 1631 | 1 |
| 1633 | 1 |
| 3781 | 1 |
| 1632 | 1 |
| 1646 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18450554 | METHOD FOR INHIBITING ADVENTITIOUS VIRAL INFECTION | ALLEN, MICHAEL D | 1671 | §103 | Non-Final OA | 27d | Pending | Aug 16, 2023 |
| 18361056 | ENGINEERED CELLS WITH REDUCED GENE EXPRESSION TO MITIGATE IMMUNE CELL RECOGNITION | ALDARONDO, DASIA ALI | 1647 | §103 | Final Rejection | 53d | Pending | Jul 28, 2023 |
| 17841041 | SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE | ZHU, JIANJIAN | 1631 | DPOther | Final Rejection | 76d | Pending | Jun 15, 2022 |
| 17550311 | METHODS AND REAGENTS FOR CHARACTERIZING CAR T CELLS FOR THERAPIES | SPENCE, JENNIFER SUZANNE | 1633 | §103 | Final Rejection | 114d overdue | Pending | Dec 14, 2021 |
| 17064241 | Plastic Jacket for Vial Labeling Systems | WENG, KAI H | 3781 | §103 | Final Rejection | 15d | Pending | Oct 06, 2020 |
| 16826102 | METHODS FOR ENHANCING TCRab+ CELL DEPLETION EFFICIENCY | DHAR, MATASHA | 1632 | §103 | Non-Final OA | 141d overdue | Pending | Mar 20, 2020 |
| 16695894 | CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN AND METHODS OF USE THEREOF | HALVORSON, MARK | 1646 | §103 | Non-Final OA | 71d overdue | Pending | Nov 26, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial